TORONTO (November 12, 2015): Today, the Canadian Medical Cannabis Council (CMCC) announced the Canadian Cancer Survivor Network (CCSN) has joined five other leading patient groups from across Canada as the newest member of the medical cannabis industry’s first Patient Advisory Committee (PAC). The Committee works to ensure patients and their best interests are the focus of the practices, activities and policy advocacy of CMCC.
“CMCC and CCSN share a deep commitment to understanding and responding patient priorities,” says Philippe Lucas, CMCC’s Interim Executive Director. “CCSN is a welcome addition to the dynamic group of CMCC advocates already hard at work.”
The Canadian Cancer Survivor Network believes empowering collaborative action by cancer patients, families and communities and educating both the public and policy makers can help identify and remove barriers to optimal patient care.
“Since our inception, CCSN has worked to have cancer patients and survivors invited to participate in significant ways in discussions related to developing and implementing policy related to cancer care,” says Jackie Manthorne, CCSN President and CEO. “We are proud to join CMCC’s Patient Advisory Committee. We look forward to our collaboration with the Committee’s other members to help ensure patients and their voices are added to and valued in the medical cannabis conversation.”
About the Canadian Cancer Survivor Network (CCSN)
The Canadian Cancer Survivor Network is a national network of patients, families, survivors, friends, community partners and sponsors. Its mission is to work together by taking action to promote the very best standard of care, support, follow up and quality of life for cancer patients and survivors. It aims to educate the public and policy makers about cancer survivorship and encourage research on ways to alleviate barriers to optimal cancer care in Canada.
About the Canadian Medical Cannabis Council (CMCC)
The Canadian Medical Cannabis Council is an industry group representing stakeholders who are committed to advancing the highest standards of integrity, safety, quality, access, security and research within Canada’s medical cannabis industry. All CMCC members are required to adhere to a Code of Ethics designed to serve patients’ best interests.